Company Provivamed Srl with Fiscal Code 34829829
recorded a turnover of 2024 of
226.283,
with a net profit of
36.381
and having an average number of employees of
5.
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Provivamed Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
15.873
34.546
42.272
56.890
77.626
95.371
91.633
176.961
226.283
Total Income - EUR
-
15.874
34.546
42.272
56.890
78.960
95.465
92.115
176.986
226.285
Total Expenses - EUR
-
12.873
25.892
32.908
36.922
59.357
80.808
87.188
128.213
183.178
Gross Profit/Loss - EUR
-
3.001
8.655
9.364
19.968
19.602
14.657
4.927
48.773
43.107
Net Profit/Loss - EUR
-
2.683
8.309
8.941
19.387
19.055
13.714
4.102
47.003
36.381
Employees
-
1
1
1
1
3
4
4
4
5
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 28.6%, from 176.961 euro in the year 2023, to 226.283 euro in 2024.
The Net Profit decreased by -10.359 euro, from 47.003 euro in 2023, to 36.381 in the last year.
Check the financial reports for the company - Provivamed Srl
Financial Rating - PROVIVAMED SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Provivamed Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Provivamed Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Provivamed Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
32.039 euro in 2024 which includes Inventories of
0 euro, Receivables of
7.924 euro and cash availability of
24.115 euro.
The company's Equity was valued at
40.929 euro, while total Liabilities amounted to
6.693 euro.
Equity decreased by -5.860 euro, from 47.052 euro in 2023, to 40.929 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Provivamed Srl